Citigroup
ALXN

Citigroup’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,404,598
Closed -$809M 5744
2021
Q2
$809M Buy
4,404,598
+1,122,326
+34% +$206M 0.49% 16
2021
Q1
$502M Buy
3,282,272
+2,159,567
+192% +$330M 0.32% 32
2020
Q4
$175M Buy
1,122,705
+279,199
+33% +$43.6M 0.1% 106
2020
Q3
$96.5M Buy
843,506
+48,713
+6% +$5.57M 0.06% 161
2020
Q2
$89.2M Buy
794,793
+69,687
+10% +$7.82M 0.07% 158
2020
Q1
$65.1M Sell
725,106
-23,917
-3% -$2.15M 0.06% 171
2019
Q4
$81M Sell
749,023
-61,973
-8% -$6.7M 0.06% 181
2019
Q3
$79.4M Buy
810,996
+144,525
+22% +$14.2M 0.06% 183
2019
Q2
$87.3M Buy
666,471
+228,725
+52% +$30M 0.07% 167
2019
Q1
$59.2M Buy
437,746
+167,921
+62% +$22.7M 0.06% 186
2018
Q4
$26.3M Buy
269,825
+60,562
+29% +$5.9M 0.03% 377
2018
Q3
$29.1M Buy
209,263
+30,599
+17% +$4.25M 0.03% 349
2018
Q2
$22.2M Sell
178,664
-38,036
-18% -$4.72M 0.02% 420
2018
Q1
$24.2M Buy
216,700
+68,262
+46% +$7.61M 0.02% 387
2017
Q4
$17.8M Buy
148,438
+24,325
+20% +$2.91M 0.01% 465
2017
Q3
$17.4M Sell
124,113
-17,882
-13% -$2.51M 0.01% 480
2017
Q2
$17.3M Buy
141,995
+56,894
+67% +$6.92M 0.02% 449
2017
Q1
$10.3M Sell
85,101
-83,309
-49% -$10.1M 0.01% 610
2016
Q4
$20.6M Buy
168,410
+111,509
+196% +$13.6M 0.02% 398
2016
Q3
$6.97M Buy
56,901
+7,202
+14% +$883K 0.01% 695
2016
Q2
$5.8M Sell
49,699
-3,972
-7% -$464K 0.01% 730
2016
Q1
$7.47M Buy
53,671
+7,344
+16% +$1.02M 0.01% 639
2015
Q4
$8.84M Sell
46,327
-68,947
-60% -$13.2M 0.01% 626
2015
Q3
$18M Sell
115,274
-12,404
-10% -$1.94M 0.02% 378
2015
Q2
$23.1M Buy
127,678
+27,701
+28% +$5.01M 0.02% 345
2015
Q1
$17.3M Buy
99,977
+14,340
+17% +$2.48M 0.02% 416
2014
Q4
$15.8M Buy
85,637
+23,827
+39% +$4.41M 0.01% 416
2014
Q3
$10.3M Sell
61,810
-20,067
-25% -$3.33M 0.01% 578
2014
Q2
$12.8M Buy
81,877
+1,366
+2% +$213K 0.01% 520
2014
Q1
$12.2M Sell
80,511
-118,639
-60% -$18M 0.01% 509
2013
Q4
$26.5M Buy
199,150
+709
+0.4% +$94.3K 0.02% 310
2013
Q3
$23.1M Sell
198,441
-2,573
-1% -$299K 0.02% 338
2013
Q2
$18.5M Buy
+201,014
New +$18.5M 0.02% 389